Identity
HGNC
LOCATION
6p21.1
LOCUSID
ALIAS
MVCD1,VEGF,VPF
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 7422
MIM: 192240
HGNC: 12680
Ensembl: ENSG00000112715
Variants:
dbSNP: 7422
ClinVar: 7422
TCGA: ENSG00000112715
COSMIC: VEGFA
RNA/Proteins
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
PharmGKB
| Entity ID | Name | Type | Evidence | Association | PK | PD | PMIDs |
|---|---|---|---|---|---|---|---|
| PA128406956 | fluorouracil | Chemical | ClinicalAnnotation | associated | PD | 20125120, 24090479, 25955730 | |
| PA130232992 | bevacizumab | Chemical | ClinicalAnnotation, Pathway | associated | PD | 20124951, 20125120, 23149126, 23953100, 25955730, 26100253, 27139155 | |
| PA131285527 | oxaliplatin | Chemical | ClinicalAnnotation | associated | PD | 20125120, 24090479, 25955730 | |
| PA134850558 | Macular Degeneration | Disease | ClinicalAnnotation | associated | PD | 22840423, 23149126, 23559864, 23570466, 23842101 | |
| PA150481189 | taxanes | Chemical | ClinicalAnnotation | associated | PD | 26194361 | |
| PA162372840 | sunitinib | Chemical | ClinicalAnnotation | associated | PD | 22948895 | |
| PA164746012 | ranibizumab | Chemical | ClinicalAnnotation | associated | PD | 22840423, 23149126, 23559864, 23570466, 23842101, 23953100 | |
| PA164771236 | pegaptanib | Chemical | ClinicalAnnotation | associated | PD | 23953100 | |
| PA166114377 | hand-foot syndrome | Disease | ClinicalAnnotation | associated | PD | 22736425 | |
| PA166114943 | regorafenib | Chemical | LabelAnnotation | associated | |||
| PA166118342 | aflibercept | Chemical | Pathway | associated | 20124951 | ||
| PA28180 | FLT1 | Gene | Pathway | associated | 20124951 | ||
| PA30086 | KDR | Gene | Pathway | associated | 20124951 | ||
| PA31783 | NRP1 | Gene | Pathway | associated | 20124951 | ||
| PA443560 | Breast Neoplasms | Disease | ClinicalAnnotation | associated | PD | 24061601, 25111199, 25955730, 26100253, 27139155 | |
| PA443624 | Carcinoma, Renal Cell | Disease | ClinicalAnnotation | associated | PD | ||
| PA444447 | Carcinoma, Hepatocellular | Disease | ClinicalAnnotation | associated | PD | 22736425, 24510746 | |
| PA444552 | Hypertension | Disease | ClinicalAnnotation | associated | PD | 26002049 | |
| PA444606 | Erectile Dysfunction | Disease | ClinicalAnnotation | associated | PD | 23007311 | |
| PA445204 | Ovarian Neoplasms | Disease | ClinicalAnnotation | associated | PD | 26194361 | |
| PA445425 | Prostatic Neoplasms | Disease | ClinicalAnnotation, VariantAnnotation | ambiguous | PK | PD | 23860526, 25111199 |
| PA445742 | Stomach Neoplasms | Disease | ClinicalAnnotation | associated | PD | 24090479 | |
| PA446108 | Colorectal Neoplasms | Disease | ClinicalAnnotation | associated | PD | 20125120, 25955730, 26100253, 27139155 | |
| PA446974 | Choroidal Neovascularization | Disease | ClinicalAnnotation | associated | PD | 23953100 | |
| PA448771 | capecitabine | Chemical | ClinicalAnnotation | associated | PD | 20125120, 25955730 | |
| PA448803 | carboplatin | Chemical | ClinicalAnnotation | associated | PD | 26194361 | |
| PA448871 | celecoxib | Chemical | Pathway | associated | 22336956 | ||
| PA449014 | cisplatin | Chemical | ClinicalAnnotation | associated | PD | 24090479 | |
| PA449165 | cyclophosphamide | Chemical | ClinicalAnnotation, VariantAnnotation | ambiguous | PD | 23860526, 25111199 | |
| PA449383 | docetaxel | Chemical | ClinicalAnnotation | associated | PD | 24061601, 25111199, 26100253 | |
| PA449456 | enalapril | Chemical | ClinicalAnnotation | associated | PD | 26002049 | |
| PA450085 | irinotecan | Chemical | ClinicalAnnotation | associated | PD | 20125120, 25955730 | |
| PA450198 | leucovorin | Chemical | ClinicalAnnotation | associated | PD | 20125120, 25955730 | |
| PA451346 | sildenafil | Chemical | ClinicalAnnotation | associated | PD | 23007311 | |
| PA7000 | sorafenib | Chemical | ClinicalAnnotation | associated | PD | 22736425, 24510746 |
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 36121037 | 2024 | VEGF and Neuronal Survival. | 0 |
| 36330643 | 2024 | Hsa_circ_0004662 Accelerates the Progression of Osteoarthritis via the microRNA-424-5p/VEGFA Axis. | 3 |
| 37392242 | 2024 | The Relation of VEGFA, VEGFR2, VEGI, and HIF1A Genetic Variants and Their Serum Protein Levels with Breast Cancer in Egyptian Patients. | 0 |
| 37573262 | 2024 | HMOX1 Participates in Pre-Eclampsia by Regulating the Proliferation, Apoptosis, and Angiogenesis Modulation Potential of Mesenchymal Stem Cells via VEGF. | 0 |
| 37592783 | 2024 | mirna-383-5p Functions as an Anti-oncogene in Glioma through the Akt/mTOR Signaling Pathway by Targeting VEGFA. | 0 |
| 37749912 | 2024 | Vascular Endothelial Growth Factor A serum levels and common gene polymorphisms in generalized periodontitis affected patients. | 1 |
| 37921969 | 2024 | MiR-150-5p contributes to unexplained recurrent spontaneous abortion by targeting VEGFA and downregulating the PI3K/AKT/mTOR signaling pathway. | 0 |
| 37957027 | 2024 | Overexpression of VEGFA mediated by HIF-1 is associated with higher rate of spread through air spaces in resected lung adenocarcinomas. | 0 |
| 37966260 | 2024 | Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression. | 5 |
| 38052425 | 2024 | Association Between VEGF-460C/T Gene Polymorphism and Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus: A Meta-Analysis. | 0 |
| 38070471 | 2024 | Estrogen, progesterone, cortisol, brain-derived neurotrophic factor, and vascular endothelial growth factor during the luteal phase of the menstrual cycle in women with premenstrual dysphoric disorder. | 0 |
| 38078693 | 2024 | Role of the VEGF in virus-associated cancers. | 1 |
| 38108278 | 2024 | Oxidative Stress Participates in Age-Related Cataract Formation by Disrupting Connection between Lens Epithelial Cells through c-Src/VEGF Pathway. | 0 |
| 38160360 | 2024 | A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5. | 0 |
| 38233982 | 2024 | THBS1 promotes angiogenesis and accelerates ESCC malignant progression by the HIF-1/VEGF signaling pathway. | 1 |
Citation
Dessen P
VEGFA (vascular endothelial growth factor A)
Atlas Genet Cytogenet Oncol Haematol. 2003-02-01
Online version: http://atlasgeneticsoncology.org/gene/42787/vegfa-(vascular-endothelial-growth-factor-a)
